CNTB Financials
Connect Biopharma Holdings Ltd - Financial statements & key metrics
Stock Price
$2.42
Market Cap
$63.34M
P/E Ratio
-8.6
EPS
$-0.89
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$26.03M
Gross Profit
-
Operating Income
-
Net Income
$-15.63M
EPS (Diluted)
$-0.28
Balance Sheet Highlights
Total Assets
$101.28M
Total Liabilities
$9.12M
Shareholders Equity
-
Cash & Equivalents
$78.23M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-23.61M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Operating Margin
-110481.3%
ROE
-66.8%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is CNTB revenue?
CNTB's most recent quarterly revenue was $26.03M. Annual revenue can be calculated by summing the four most recent quarters.
Is CNTB profitable?
CNTB reported a loss of $15.63M in the most recent quarter.
What is CNTB market cap?
CNTB has a market capitalization of $63.34M, making it a small-cap stock.
Does CNTB have debt?
View CNTB's balance sheet for debt information.
What is CNTB cash flow?
Cash flow data is available in the full financial statements.